BOUL: Boule Diagnostics AB (publ) - Summary | Jitta

Boule Diagnostics AB (publ)

SWE:BOUL

Price
kr3.21
Loss Chance
46.5%
3.43JITTA SCORE
14.80%Under Jitta Line
Jitta Ranking
16 / 106
141 / 617
Grow your money with Jitta Ranking. See details.
HISTORICAL JITTA SCORE
Jitta Factors
Growth Opportunity (29)
Recent Business Performance (29)
Financial Strength (69)
Return to Shareholders (26)
Competitive Advantage (38)
Jitta Signs
Revenue and EarningEarning loss detected in 2020
Operating MarginDeclined
Recent Business PerformanceEarning decline 40.12% in the last year
New Share IssuedMore than 50% in 5 years
Key Stats
Jitta Score
Jitta Line
3.43
14.80%
2.93
161.44%
Health Care Equipment
3.67
100.00%
4.58
32.09%
4.08
47.55%
COMPANY DESCRIPTION
Boule Diagnostics AB (publ) develops, manufactures, and markets instruments and consumable products for blood diagnostics in the United States of America, Asia, Eastern Europe, Latin America, Western Europe, Africa, and the Middle East. It operates through Diagnostics and OEM Clinical Diagnostic Solutions. The company provides hematology analyzers, reagents, controls, and calibrators, under the Swelab, and Medonic brands; and veterinary hematology and clinical chemistry analyzer systems, as well as reagents and panels under the Exigo brand. It serves small and medium-sized hospitals, clinics, laboratories, and veterinary clinics, and other diagnostics firms. The company was founded in 1956 and is headquartered in Spånga, Sweden.